The Role of CD34+ Stem Cells in the Pathogenesis of Takotsubo Syndrome

Recruiting now

Conditions studied: Tako Tsubo Cardiomyopathy, Microvascular Dysfunction, CD34+ Stem Cells, Heart Failure, Cardiac Contractility Recovery

In brief

The underlying mechanisms of microvascular dysfunction in Takotsubo cardiomyopathy remain incompletely understood. As CD34+ cells are essential to coronary microvascular homeostasis we will investigate the potential association between CD34+ cell count and changes in left ventricular function in patients with Takotsubo cardiomyopathy at baseline and 6-month follow-up.

Key facts

Study ID
NCT07604467
Run by
University Medical Centre Ljubljana
People needed
40
Starts
2021-09-06
Expected to finish
2026-12-31
Last updated by the study team
2026-05-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.